Provided by Tiger Trade Technology Pte. Ltd.

Denali Therapeutics Inc.

20.38
-0.8400-3.96%
Pre-market: 21.481.10+5.40%09:12 EDT
Volume:1.84M
Turnover:37.54M
Market Cap:3.26B
PE:-7.19
High:21.10
Open:21.01
Low:20.27
Close:21.22
52wk High:27.30
52wk Low:12.58
Shares:159.85M
Float Shares:151.07M
Volume Ratio:1.31
T/O Rate:1.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8353
EPS(LYR):-2.9700
ROE:-54.93%
ROA:-29.15%
PB:3.90
PE(LYR):-6.86

Loading ...

Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Major Issues Report

Form 8-K - Current report
Dec 10, 2025

Major Issues Report

Form 8-K - Current report
Dec 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2025

Major Issues Report

Form 8-K - Current report
Dec 04, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 14, 2025

Major Issues Report

Form 8-K - Current report
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]